Atlas Trials

A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-Severe Ulcerative Colitis

Clinical trial NCT07758101 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07758101
Sponsor
Guangdong Hengrui Pharmaceutical Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Moderate to Severe Ulcerative Colitis
Start date
2026-08-01
Primary completion
2027-01-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.